Propentofylline targets TROY, a novel microglial signaling pathway

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Jacobs, Valerie L ^a,b   Liu, Yingna ^a   de Leo, Joyce A ^a,b,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Neuroscience Center at Dartmouth   (United States)

^c EMMANUEL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROPENTOFYLLINE; TUMOR NECROSIS FACTOR RECEPTOR OF MOUSE EMBRYO; UNCLASSIFIED DRUG; FOCAL ADHESION KINASE 2; NEUROPEPTIDE; PTK2B PROTEIN, MOUSE; RAC PROTEIN; RAC1 PROTEIN, MOUSE; SMALL INTERFERING RNA; TNFRSF19 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR; XANTHINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GLIOMA; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; PROTEIN TARGETING; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CELL MOTION; COMPARATIVE STUDY; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

RATTUS; RODENTIA;

ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; FLOW CYTOMETRY; FOCAL ADHESION KINASE 2; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEUROPEPTIDES; RAC GTP-BINDING PROTEINS; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; XANTHINES;

EID: 84861395022     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037955     Document Type: Article

References (31)

1. DeAngelis LM, (2005) Chemotherapy for brain tumors-a new beginning. N Engl J Med 352: 1036-1038.
2. Ohgaki H, Kleihues P, (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64: 479-489.
3. Roggendorf W, Strupp S, Paulus W, (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92: 288-293.
4. Yang I, Han SJ, Kaur G, Crane C, Parsa AT, (2010) The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci 17: 6-10.
5. Tuettenberg J, Grobholz R, Seiz M, Brockmann MA, Lohr F, et al. (2009) Recurrence pattern in glioblastoma multiforme patients treated with anti-angiogenic chemotherapy. J Cancer Res Clin Oncol 135: 1239-1244.
6. Gabrusiewicz KE-MA, Lipko M, Sielska M, Frankowska M, Kaminska B, (2011) Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One 6.
7. Wu A, Wei J, Kong LY, Wang Y, Priebe W, et al. (2010) Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 12: 1113-1125.
8. Sliwa MMD, Gabrusiewicz K, Synowitz M, Glass R, Zawadzka M, Wesolowska A, Kettenmann H, Kaminska B, (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 130: 478-489.
9. Jacobs VL, Landry RP, Liu Y, Romero-Sandoval EA, De Leo JA, (2011) Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol.
10. D'Abaco GM, Kaye AH, (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14: 1041-1048.
11. Aplin AE, Howe A, Alahari SK, Juliano RL, (1998) Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50: 197-263.
12. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, et al. (2001) Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53: 161-176.
13. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, et al. (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7: 7-16.
14. Veroni C, Gabriele L, Canini I, Castiello L, Coccia E, et al. (2010) Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Mol Cell Neurosci 45: 234-244.
15. Paulino VM, Yang Z, Kloss J, Ennis MJ, Armstrong BA, et al. (2010) TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res 8: 1558-1567.
16. Park JB, Yiu G, Kaneko S, Wang J, Chang J, et al. (2005) A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45: 345-351.
17. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, et al. (2005) TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 45: 353-359.
18. Qiu W, Hu Y, Andersen TE, Jafari A, Li N, et al. (2010) Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP. J Biol Chem 285: 14438-14449.
19. Sweitzer S, De Leo J, (2011) Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol pp. 235-250.
20. Nagata K, Ogawa T, Omosu M, Fujimoto K, Hayashi S, (1985) In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity. Arzneimittelforschung 35: 1034-1036.
21. Fredholm BB, Lindstrom K, (1986) The xanthine derivative 1-(5′-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine. Acta Pharmacol Toxicol (Copenh) 58: 187-192.
22. Kruse CA, Molleston MC, Parks EP, Schiltz PM, Kleinschmidt-DeMasters BK, et al. (1994) A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9 L gliosarcoma. J Neurooncol 22: 191-200.
23. Nutile-McMenemy N, Elfenbein A, Deleo JA, (2007) Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression. J Neurochem 103: 2035-2046.
24. Horvath RJ, Nutile-McMenemy N, Alkaitis MS, Deleo JA, (2008) Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J Neurochem 107: 557-569.
25. Tsui CC, Shankland SJ, Pierchala BA, (2006) Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury. J Am Soc Nephrol 17: 1543-1552.
26. Pollard JW, (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78.
27. Yeh WL, Lu DY, Liou HC, Fu WM, (2012) A forward loop between glioma and microglia: Glioma-derived extracellular matrix-activated microglia secrete IL-18 to enhance the migration of glioma cells. J Cell Physiol 227: 558-568.
28. Gilbert MR, (2011) Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches. Semin Oncol 38 (Suppl 4): S21-33.
29. Eby MT, Jasmin A, Kumar A, Sharma K, Chaudhary PM, (2000) TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J Biol Chem 275: 15336-15342.
30. Hu S, Tamada K, Ni J, Vincenz C, Chen L, (1999) Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily. Genomics 62: 103-107.
31. Morikawa Y, Hisaoka T, Kitamura T, Senba E, (2008) TROY, a novel member of the tumor necrosis factor receptor superfamily in the central nervous system. Ann N Y Acad Sci 1126: A1-10.